Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Gagniere C, Bouhnik Y; OBSERV-IBD study group and the GETAID.

Aliment Pharmacol Ther. 2017 Aug;46(3):310-321. doi: 10.1111/apt.14167. Epub 2017 Jun 8.

PMID:
28593685
2.

Computer-Aided Classification of Gastrointestinal Lesions in Regular Colonoscopy.

Mesejo P, Pizarro D, Abergel A, Rouquette O, Beorchia S, Poincloux L, Bartoli A.

IEEE Trans Med Imaging. 2016 Sep;35(9):2051-2063. doi: 10.1109/TMI.2016.2547947.

PMID:
28005009
3.

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.

Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Bouhnik Y; Observatory on Efficacy and of Vedolizumab in Patients With Inflammatory Bowel Disease Study Group; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1593-1601.e2. doi: 10.1016/j.cgh.2016.02.016. Epub 2016 Feb 22.

PMID:
26917043
4.

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.

Melin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Lang JP, Marcellin P, Cacoub P; CheObs Study Group.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1050-7. doi: 10.1097/MEG.0b013e328338d9aa.

PMID:
20351554
5.

Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.

Cortot A, Maetz D, Degoutte E, Delette O, Meunier P, Tan G, Cazals JB, Dewit O, Hebuterne X, Beorchia S, Grunberg B, Leprince E, D'Haens G, Forestier S, Idier I, Lémann M.

Am J Gastroenterol. 2008 Dec;103(12):3106-14. doi: 10.1111/j.1572-0241.2008.02152.x.

PMID:
19086960
6.

Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.

Fontanges T, Bailly F, Trepo E, Chevallier M, Maynard-Muet M, Nalet B, Beorchia S, Pillon D, Moindrot H, Froissart B, Slaoui M, Tinel X, Pradat P, Trepo C.

Gastroenterol Clin Biol. 2008 Oct;32(10):858-65. doi: 10.1016/j.gcb.2008.05.019. Epub 2008 Sep 4.

7.

Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study.

Mion F, Gincul R, Roman S, Beorchia S, Hedelius F, Claudel N, Bory RM, Malvoisin E, Trepo F, Napoleon B.

Obes Surg. 2007 Jun;17(6):764-9. Erratum in: Obes Surg. 2007 Jul;17(7):996.

PMID:
17879576
8.

Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection.

Fontanges T, Beorchia S, Douvin C, Delassalle P, Combis JM, Hanslik B, Jacques JP, Filoche B, Desmorat H, Chandelier C, Ouzan D.

Gastroenterol Clin Biol. 2007 Jun-Jul;31(6-7):566-72.

9.

[Subtotal colectomy under celioscopy].

Lointier P, Ferrier C, Dapoigny M, Beorchia S, Chipponi J.

J Chir (Paris). 1993 Mar;130(3):116-20. French.

PMID:
8320296
10.

Nocturnal plasma melatonin levels in migraine: a preliminary report.

Claustrat B, Loisy C, Brun J, Beorchia S, Arnaud JL, Chazot G.

Headache. 1989 Apr;29(4):242-5.

PMID:
2714976
11.

[Hepatic anomalies in Mediterranean boutonneuse fever].

Beorchia S, Rouhier D, Woehrlé R, Monin F, Evreux M, Brette R.

Ann Gastroenterol Hepatol (Paris). 1986 Mar-Apr;22(2):87-90. French.

PMID:
3717890
12.

Effects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study.

Loisy C, Beorchia S, Centonze V, Fozard JR, Schechter PJ, Tell GP.

Cephalalgia. 1985 Jun;5(2):79-82.

PMID:
3893732
13.

[Evaluation of serum beta 2-microglobulin levels in immunologically mediated liver disease].

Beorchia S, Trépo C, Vincent C, Revillard JP, Brette R.

Gastroenterol Clin Biol. 1982 Aug-Sep;6(8-9):679-87. French. No abstract available.

PMID:
6182052
14.

Elevation of serum beta 2 microglobulin in liver diseases.

Beorchia S, Vincent C, Revillard JP, Trepo C.

Clin Chim Acta. 1981 Feb 5;109(3):245-55.

PMID:
6164510
15.

[The interaction of cellular immunity and of viral factors in the pathogenesis and the resolution of HB virus infections in hemodialysis (author's transl)].

Beorchia S, Touraine JL, Trepo C, Revillard JP, Sepetjian M, Brette R, Traeger J.

Nouv Presse Med. 1980 Feb 16;9(8):505-8. French.

PMID:
7367282
16.

[Demonstration of a serum and liver antigen in acute or chronic non A-non B viral hepatitis].

Trepo C, Vitvitski L, Pichoud C, Perche G, Beorchia S, Sepetjan M, Brette R.

Nouv Presse Med. 1979 Nov 5;8(43):3539-42. French.

PMID:
120941

Supplemental Content

Loading ...
Support Center